Solu-cortef
(8S,9S,10R,11S,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 5754.
Registration
- Applicants
- 2
- Registrations
- 2
Applicants and registrations
Variants
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Hydrocortisone
- maximum concentration of 1 percent in preparations intended for application to the skin, and
- in a maximum concentration of 1 percent used in combination with miconazole for topical application in the treatment of athlete’s foot. (S2)
Consolidated Schedules 06 July 2026, lines 6648 to 6652
S2: Hydrocortisone
- maximum concentration of 1 percent in preparations intended for application to the skin, and
- in a maximum concentration of 1 percent used in combination with miconazole for topical application in the treatment of athlete’s foot. (S4)
Consolidated Schedules 06 July 2026, lines 2110 to 2114
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.